Early Diagnosis and Treatment of Purine Nucleoside Phosphorylase (PNP) Deficiency through TREC-Based Newborn Screening
Abstract
Purine nucleoside phosphorylase (PNP) deficiency is a rare inherited disorder, resulting in severe combined immunodeficiency. To date, PNP deficiency has been detected in newborn screening only through the use of liquid chromatography tandem mass spectrometry. We report the first case in which PNP deficiency was detected by TREC analysis.
Keywords
Newborn screening; Severe combined immunodeficiency
Bibliographic citation
Martín-Nalda A, Rivière JG, Català-Besa M, García-Prat M, Parra-Martínez A, Martínez-Gallo M, et al. Early Diagnosis and Treatment of Purine Nucleoside Phosphorylase (PNP) Deficiency through TREC-Based Newborn Screening. Int J Neonatal Screen. 2021 Dec;7(4):62.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/7491This item appears in following collections
- HVH - Articles científics [2491]
- VHIR - Articles científics [1015]
The following license files are associated with this item: